电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

HLA-DRA 抗体

HLA-DRA 适用: 人, 猴 FACS, IF 宿主: 小鼠 Monoclonal IPO-10 unconjugated
产品编号 ABIN6939635
发货至: 中国
  • 抗原 See all HLA-DRA 抗体
    HLA-DRA (HLA Class II DR alpha (HLA-DRA))
    适用
    • 83
    • 16
    • 10
    • 10
    • 9
    • 9
    • 3
    • 2
    • 2
    • 1
    人, 猴
    宿主
    • 56
    • 42
    • 1
    • 1
    小鼠
    克隆类型
    • 57
    • 43
    单克隆
    标记
    • 48
    • 12
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    This HLA-DRA antibody is un-conjugated
    应用范围
    • 44
    • 43
    • 33
    • 31
    • 16
    • 11
    • 10
    • 9
    • 9
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunofluorescence (IF)
    特异性
    MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50 % of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70 % of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected. '
    纯化方法
    Purified by Protein A/G
    免疫原
    Spleen cells of a patient with hairy cell leukemia (Daudi cells)
    克隆位点
    IPO-10
    亚型
    IgG3 kappa
    Top Product
    Discover our top product HLA-DRA Primary Antibody
  • 应用备注

    Positive Control: Ramos, Daudi or HuT78 cells. Tonsil or lymph node.

    Known Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Optimal dilution for a specific application should be determined.

    限制
    仅限研究用
  • 浓度
    200 μg/mL
    缓冲液
    10 mM PBS with 0.05 % BSA & 0.05 % azide.
    储存液
    Sodium azide
    注意事项
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    储存条件
    4 °C,-80 °C
    储存方法
    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
    有效期
    24 months
  • 抗原
    HLA-DRA (HLA Class II DR alpha (HLA-DRA))
    别名
    HLA-DRA (HLA-DRA 产品)
    别名
    HLA-DRA1 antibody, MLRW antibody, DR-alpha antibody, HLA-DRA antibody, Mamu-DRA1 antibody, major histocompatibility complex, class II, DR alpha L homeolog antibody, major histocompatibility complex, class II, DR alpha antibody, hla-dra.L antibody, HLA-DRA antibody, MAMU-DRA antibody, BOLA-DRA antibody
    分子量
    ~36kDa
    基因ID
    3122
    UniProt
    P01903
    途径
    TCR Signaling, CXCR4-mediated Signaling Events
You are here:
客服